156 related articles for article (PubMed ID: 34865975)
21. Current strategies and future directions of antiangiogenic tumor therapy.
Zhang ZL; Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic therapy for cancer: an update.
Al-Husein B; Abdalla M; Trepte M; Deremer DL; Somanath PR
Pharmacotherapy; 2012 Dec; 32(12):1095-111. PubMed ID: 23208836
[TBL] [Abstract][Full Text] [Related]
23. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
24. Developing and understanding biofluid vibrational spectroscopy: a critical review.
Baker MJ; Hussain SR; Lovergne L; Untereiner V; Hughes C; Lukaszewski RA; Thiéfin G; Sockalingum GD
Chem Soc Rev; 2016 Apr; 45(7):1803-18. PubMed ID: 26612430
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
26. Raman micro-spectroscopy: a powerful tool for the monitoring of dynamic supramolecular changes in living cells.
Caponi S; Liguori L; Giugliarelli A; Mattarelli M; Morresi A; Sassi P; Urbanelli L; Musio C
Biophys Chem; 2013 Dec; 182():58-63. PubMed ID: 23850174
[TBL] [Abstract][Full Text] [Related]
27. Vibration spectroscopy and body biofluids: Literature review for clinical applications.
Leal LB; Nogueira MS; Canevari RA; Carvalho LFCS
Photodiagnosis Photodyn Ther; 2018 Dec; 24():237-244. PubMed ID: 30282049
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
Tartour E; Pere H; Maillere B; Terme M; Merillon N; Taieb J; Sandoval F; Quintin-Colonna F; Lacerda K; Karadimou A; Badoual C; Tedgui A; Fridman WH; Oudard S
Cancer Metastasis Rev; 2011 Mar; 30(1):83-95. PubMed ID: 21249423
[TBL] [Abstract][Full Text] [Related]
29. Raman optical activity spectra and conformational elucidation of chiral drugs. The case of the antiangiogenic aeroplysinin-1.
Nieto-Ortega B; Casado J; Blanch EW; López Navarrete JT; Quesada AR; Ramírez FJ
J Phys Chem A; 2011 Apr; 115(13):2752-5. PubMed ID: 21401047
[TBL] [Abstract][Full Text] [Related]
30. Isolation and screening of proangiogenic and antiangiogenic metabolites producing rare actinobacteria from soil.
Azarakhsh Y; Mohammadipanah F; Nassiri SM; Siavashi V; Hamedi J
J Appl Microbiol; 2017 Jun; 122(6):1595-1602. PubMed ID: 28370967
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.
Pircher A; Jöhrer K; Kocher F; Steiner N; Graziadei I; Heidegger I; Pichler R; Leonhartsberger N; Kremser C; Kern J; Untergasser G; Gunsilius E; Hilbe W
Oncotarget; 2016 Apr; 7(15):20109-23. PubMed ID: 26956051
[TBL] [Abstract][Full Text] [Related]
32. Statistical strategies to reveal potential vibrational markers for in vivo analysis by confocal Raman spectroscopy.
Oliveira Mendes Td; Pinto LP; Santos LD; Tippavajhala VK; Téllez Soto CA; Martin AA
J Biomed Opt; 2016 Jul; 21(7):75010. PubMed ID: 27411080
[TBL] [Abstract][Full Text] [Related]
33. A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.
Butler CT; Reynolds AL; Tosetto M; Dillon ET; Guiry PJ; Cagney G; O'Sullivan J; Kennedy BN
J Biol Chem; 2017 Mar; 292(9):3552-3567. PubMed ID: 28035003
[TBL] [Abstract][Full Text] [Related]
34. Advantages and limitations of Raman spectroscopy for molecular diagnostics: an update.
Eberhardt K; Stiebing C; Matthäus C; Schmitt M; Popp J
Expert Rev Mol Diagn; 2015 Jun; 15(6):773-87. PubMed ID: 25872466
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative and antiangiogenic effect of Amblyomma sculptum (Acari: Ixodidae) crude saliva in endothelial cells in vitro.
de Sá Junior PL; Dias Câmara DA; Sciani JM; Porcacchia AS; Moreira Fonseca PM; Mendonça RZ; Elifio-Esposito S; Simons SM
Biomed Pharmacother; 2019 Feb; 110():353-361. PubMed ID: 30529768
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers for monitoring antiangiogenic therapy.
Bhatt RS; Seth P; Sukhatme VP
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):777s-780s. PubMed ID: 17255309
[TBL] [Abstract][Full Text] [Related]
37. Raman and Fourier transform infrared imaging for characterization of bone material properties.
Taylor EA; Donnelly E
Bone; 2020 Oct; 139():115490. PubMed ID: 32569874
[TBL] [Abstract][Full Text] [Related]
38. The indirect antiangiogenic effect of IL-37 in the tumor microenvironment.
Mei Y; Zhu Y; Teo HY; Liu Y; Song Y; Lim HY; Binte Hanafi Z; Angeli V; Liu H
J Leukoc Biol; 2020 May; 107(5):783-796. PubMed ID: 32125036
[TBL] [Abstract][Full Text] [Related]
39. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
Wilson PM; LaBonte MJ; Lenz HJ
Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
[TBL] [Abstract][Full Text] [Related]
40. Vibrational spectroscopy--a powerful tool for the rapid identification of microbial cells at the single-cell level.
Harz M; Rösch P; Popp J
Cytometry A; 2009 Feb; 75(2):104-13. PubMed ID: 19156822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
